Essex Bio-Technology Limited (HKG:1061)
Hong Kong
· Delayed Price · Currency is HKD 4.540
+0.140 (3.18%)
Apr 29, 2025, 4:08 PM HKT
Essex Bio-Technology Revenue
In the year 2024, Essex Bio-Technology had annual revenue of 1.67B HKD, down -3.87%. Essex Bio-Technology had revenue of 858.19M in the half year ending December 31, 2024, with 29.66% growth.
Revenue
1.67B
Revenue Growth
-3.87%
P/S Ratio
1.49
Revenue / Employee
1.15M
Employees
1,450
Market Cap
2.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.67B | -67.16M | -3.87% |
| Dec 31, 2023 | 1.74B | 419.26M | 31.82% |
| Dec 31, 2022 | 1.32B | -319.95M | -19.54% |
| Dec 31, 2021 | 1.64B | 659.55M | 67.43% |
| Dec 31, 2020 | 978.11M | -301.37M | -23.55% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| CSPC Pharmaceutical Group | 30.87B |